Literature DB >> 28396991

RACK1 Silencing Induces Cell Apoptosis and Inhibits Cell Proliferation in Hepatocellular Carcinoma MHCC97-H Cells.

Yuan-Hang Zou1, Xue-Dong Li2, Qi-Hao Zhang2, De-Zhong Liu3.   

Abstract

This study aimed to explore the effects of RACK1 gene silencing on the apoptosis and proliferation of hepatocellular carcinoma (HCC) MHCC97-H cells. After transfecting MHCC97-H cells with siRNA, RACK1 gene silencing model was established. The cells were divided into blank group, siRNA group and empty plasmid group, respectively. The mRNA and protein expressions of RACK1, cyclin D1 and BAX were determined by qRT-PCR and Western blotting. CCK-8 assay, flow cytometry and FITC-Annexin V/PI staining were used to determine cell viability, cell cycle and cell apoptosis, respectively. The results of qRT-PCR and Western blotting suggested that when compared with the blank group and the empty plasmid group, the mRNA and protein expressions of RACK1 and Cyclin D1 decreased significantly while the mRNA and protein BAX expressions increased substantially in the siRNA group (all P < 0.05). The results of CCK-8 assay revealed that the siRNA group exhibited significantly lower cell viability when compared with the blank group and the empty plasmid group (both P < 0.05); and the cell viability in the siRNA group decreased gradually with the increase of time. The results of flow cytometry and FITC-Annexin V/PI staining indicated that when compared with the blank group and the empty plasmid group, the proportion of cells in S phase was markedly lower and the apoptosis rate was significantly higher in the siRNA group (both P < 0.05). Our study suggests that inhibition of RACK1 could suppress cell proliferation and induce apoptosis in HCC MHCC97-H cells.

Entities:  

Keywords:  Cell apoptosis; Cell proliferation; Gene silencing; Hepatocellular carcinoma; MHCC97-H; RACK1

Mesh:

Substances:

Year:  2017        PMID: 28396991     DOI: 10.1007/s12253-017-0214-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

Review 1.  Systematic review of actual 10-year survival following resection for hepatocellular carcinoma.

Authors:  Annelise M Gluer; Nicholas Cocco; Jerome M Laurence; Emma S Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-02-28       Impact factor: 3.647

2.  Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells.

Authors:  Vidya Mamidipudi; Laura D Miller; Daria Mochly-Rosen; Christine A Cartwright
Journal:  Biochem Biophys Res Commun       Date:  2006-11-15       Impact factor: 3.575

3.  Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.

Authors:  X He; J Wang; E M Messing; G Wu
Journal:  Oncogene       Date:  2010-09-27       Impact factor: 9.867

4.  Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.

Authors:  Renjun Peng; Bing Jiang; Jianrong Ma; Zhiming Ma; Xin Wan; Hongwei Liu; Zigui Chen; Quan Cheng; Rui Chen
Journal:  Oncol Rep       Date:  2013-09-06       Impact factor: 3.906

5.  Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort.

Authors:  Sabrina Schlesinger; Krasimira Aleksandrova; Tobias Pischon; Veronika Fedirko; Mazda Jenab; Elisabeth Trepo; Paolo Boffetta; Christina C Dahm; Kim Overvad; Anne Tjønneland; Jytte Halkjær; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Franck Carbonnel; Rudolf Kaaks; Annekatrin Lukanova; Heiner Boeing; Antonia Trichopoulou; Christina Bamia; Pagona Lagiou; Domenico Palli; Sara Grioni; Salvatore Panico; Rosario Tumino; Paolo Vineis; H B Bueno-de-Mesquita; Saskia van den Berg; Petra H M Peeters; Tonje Braaten; Elisabete Weiderpass; J Ramón Quirós; Noémie Travier; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Miren Dorronsoro; Björn Lindkvist; Sara Regner; Mårten Werner; Malin Sund; Kay-Tee Khaw; Nicholas Wareham; Ruth C Travis; Teresa Norat; Petra A Wark; Elio Riboli; Ute Nöthlings
Journal:  Int J Cancer       Date:  2012-06-13       Impact factor: 7.396

6.  Downregulation of receptor for activated C-kinase 1 (RACK1) suppresses tumor growth by inhibiting tumor cell proliferation and tumor-associated angiogenesis.

Authors:  Feng Wang; Tsuyoshi Osawa; Rika Tsuchida; Yasuhito Yuasa; Masabumi Shibuya
Journal:  Cancer Sci       Date:  2011-09-22       Impact factor: 6.716

7.  Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.

Authors:  Shashi Rajput; B N Prashanth Kumar; Kaushik Kumar Dey; Ipsita Pal; Aditya Parekh; Mahitosh Mandal
Journal:  Life Sci       Date:  2013-09-15       Impact factor: 5.037

Review 8.  Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma.

Authors:  Mary Maluccio; Anne Covey
Journal:  CA Cancer J Clin       Date:  2012-10-15       Impact factor: 508.702

Review 9.  RACK1, a versatile hub in cancer.

Authors:  J-J Li; D Xie
Journal:  Oncogene       Date:  2014-06-02       Impact factor: 9.867

Review 10.  Links between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular Carcinoma.

Authors:  Tomoyuki Honda
Journal:  Front Chem       Date:  2016-05-11       Impact factor: 5.221

View more
  1 in total

1.  Overexpression of RACK1 Predicts Poor Prognosis in Melanoma.

Authors:  Congcong Shen; Hui Hua; Lixiong Gu; Shuanglin Cao; Hengji Cai; Xiaodong Yao; Xiaodong Chen
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.